Marco Cerrano

35PUBLICATIONS

151CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Haematological tumoursTransplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (35)

Sort by Publication Date:

|May 21, 2026

T-cell acute lymphoblastic leukemia in adults: current treatment approaches and future perspectives.

|Feb 24, 2026

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Dec 05, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Sep 24, 2025

Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.

Fabio Guolo, Luana Fianchi, Maria Paola Martelli

|Aug 11, 2025

Real World Incidence and Etiology of Infectious Complications in Adults With Ph-Negative Acute Lymphoblastic Leukemia Treated With the Pediatric-Inspired GIMEMA LAL1913 Program. A Campus All Study.

Patrizia Zappasodi, Ludovica Calabretta, Virginia Valeria Ferretti

|Aug 08, 2025

Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De-Escalation: 96-Week Update of the DANTE Study.

Alessandra Iurlo, Massimo Breccia, Fabio Stagno

Pageof 6

Frequent Collaborators

Fabio Guolo

Paola Minetto

Livio Pagano

Adriano Venditti

Sara Galimberti

Massimo Breccia

Alessandro Busca

Alessandra Iurlo

Patrizia Zappasodi

Michela Rondoni

Frequent Collaborators

Fabio Guolo

Paola Minetto

Livio Pagano

Adriano Venditti